
Kikkoman Corporation
Kikkoman Corporation is a globally leading fermented seasoning manufacturer headquartered in Tokyo, Japan. With over 350 years of brand heritage, it specializes in producing and selling soy sauce, sauces, and seasonings, operating in more than 100 countries worldwide. Kikkoman runs 20 production bases globally, including 10 dedicated soy sauce factories, with total annual capacity of 800,000 tons. In 2024, it reported approximately ¥500 billion (about $4.5 billion) in revenue, with soy sauce contributing 60%. Listed on the Tokyo Stock Exchange, Kikkoman dominates the global soy sauce market with a 25% share, leveraging its unique natural fermentation technology, superior quality control, and efficient worldwide operations network.
Strengths: Kikkoman's core strengths are its absolute leadership in the global fermented seasoning market, supported by unique natural fermentation technology and 350 years of craftsmanship; unparalleled brand heritage as the world's most trusted soy sauce brand and a symbol of Japanese culture; and an extensive global production and sales network across 100+ countries with strong local adaptation capabilities.
Weaknesses: Kikkoman faces risks from business concentration, with soy sauce accounting for 60% of revenue; profitability is vulnerable to raw material cost fluctuations; and it confronts intensifying global competition alongside innovation pressures from shifting consumer tastes and health trends.Read MoreShow Less
Strengths: Kikkoman's core strengths are its absolute leadership in the global fermented seasoning market, supported by unique natural fermentation technology and 350 years of craftsmanship; unparalleled brand heritage as the world's most trusted soy sauce brand and a symbol of Japanese culture; and an extensive global production and sales network across 100+ countries with strong local adaptation capabilities.
Weaknesses: Kikkoman faces risks from business concentration, with soy sauce accounting for 60% of revenue; profitability is vulnerable to raw material cost fluctuations; and it confronts intensifying global competition alongside innovation pressures from shifting consumer tastes and health trends.
Listed market data
2801 · TSE · weeklyHistory →- Market cap
- $10.5 B
- Share price
- JPY 1811.00
- 1Y change
- +47.6%
- Recent change
- +0.4%
- Since first close
- +44.3%
10-30 → 11-02
from 2025-09
Financial history
Full market history- 2026-11JPY 1811.00$10.5 B+0.4%
- 2026-10JPY 1803.00$10.5 B+9.3%
- 2026-09JPY 1649.00$9.6 B-10.1%
- 2026-08JPY 1835.00$10.7 B+11.4%
- 2026-07JPY 1647.50$9.6 B-1.2%
- 2026-06JPY 1668.00$9.7 B+19.7%
- 2026-05JPY 1393.00$8.1 B-2.3%
- 2026-04JPY 1426.50$8.3 B-0.6%
- 2026-03JPY 1435.00$8.3 B-4.3%
- 2026-02JPY 1500.00$8.7 B+7.9%
- 2026-01JPY 1390.50$8.1 B-2.2%
- 2025-12JPY 1422.00$8.3 B—
Ownership & Control
Latest available filings- Controlling entity
- Publicly held — no controlling shareholder disclosed
- Company type
- Brand & Manufacturer
- Insiders
- —
- Institutions
- —
- Free float
- —
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →5 latest headlines- Kikkoman Corporation Estimates – TSE:2801 - TradingViewwww.tradingview.com2026-10-23
- Kikkoman reports JPY 202.03 billion first-quarter revenue: Kikkoman stock awaits November 9 results - ad-hoc-news.dewww.ad-hoc-news.de2026-10-20
- Kikkoman Corporation (2801.T) stock price, news, quote and history - Yahoo Finance Australiaau.finance.yahoo.com2026-10-09
- ETFs Investing in Kikkoman Corporation Stocks - TradingViewwww.tradingview.com2026-10-01
- Kikkoman Opens Third U.S. Plant In Wisconsin With $560 Million Planned Investment - Pulse 2.0pulse2.com2026-09-25
Quick Facts
Headquarters
Noda, Chiba Prefecture, Japan
Founded
1917
Employees
5.6K+
Market cap
$10.5 B
Presence
100+ Countries
Listing
Publicly Listed
Categories
14 categories · scroll for more
Related
Similar listed companies
- Eli Lilly and Company· $1.1 T
- Allergan Aesthetics· $521 B
- The Coca-Cola Company· $405 B
- Merck Animal Health· $369 B
- Philip Morris International Inc.· $315 B
- Nestlé S.A.Brand ( Nestlé Health Science )· $257 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: TYO : 2801
